Comorbidities influence the predictive power of hematological markers for mortality in hospitalized COVID-19 patients.

Ashwaghosha Parthasarathi Chetak Kadabasal Basavaraja Sumalatha Arunachala Shreya Chandran Hariharan Venkataraman Athira Satheesh Mahesh Padukudru Anand

Published in: Advances in respiratory medicine (2022)

In severe COVID-19 patients, CRP was the most reliable biomarker to predict mortality followed by NLR. Presence, type, and number of co-morbidities influence the levels of the biomarkers and the clinically relevant cut-offs associated with mortality.

Keyphrases

cardiovascular events
sars cov
risk factors
type diabetes
early onset
cardiovascular disease
coronary artery disease
drug induced